Skip to content
Back to ASND

Ascendis Pharma A/S

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
12
Purchases
9
Sales
3
Purchase value
$777.07K
Sale value
$5.51M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Mads BodenhoffSVP & PAO
4
Filed Sep 9, 2026Period of report Sep 8, 20260001610717-26-000409
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 8, 2026
Ordinary Shares3,000$270.19$810.57K0Direct
Filing footnotes · 1
  1. F1The warrants vested 25% on October 11, 2023 and thereafter in 36 equal monthly installments.
Open on SEC EDGAR
Lars HoltugDirector
4
Filed Sep 3, 2026Period of report Sep 2, 20260001610717-26-000395
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 2, 2026
Ordinary Shares236$264.1296$62.33K4,000Direct
Open on SEC EDGAR
Jean Jacques BienaimeDirector
4
Filed Aug 18, 2026Period of report Aug 14, 20260001610717-26-000360
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 14, 2026
Ordinary SharesF11,100$245.85$270.44K2,000Direct
PurchaseAug 14, 2026
Ordinary SharesF2900$246.91$222.22K2,900Direct
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $245.41 to $246.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. F2The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $246.48 to $247.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Scott Thomas SmithEVP & Chief Financial Officer
4
Filed Jun 2, 2026Period of report Jun 2, 20260001610717-26-000179
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJun 2, 2026
Ordinary Shares100$219.00$21.90K4,367Direct
Open on SEC EDGAR
Jean Jacques BienaimeDirector
4
Filed Jun 1, 2026Period of report May 29, 20260001610717-26-000177
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 29, 2026
Ordinary Shares200$223.76$44.75K600Direct
PurchaseMay 29, 2026
Ordinary Shares200$222.30$44.46K800Direct
PurchaseMay 29, 2026
Ordinary Shares100$223.50$22.35K900Direct
Open on SEC EDGAR
Scott Thomas SmithEVP & Chief Financial Officer
4
Filed Jun 1, 2026Period of report May 29, 20260001610717-26-000176
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 29, 2026
Ordinary Shares250$223.32$55.83K4,267Direct
Open on SEC EDGAR
Jean Jacques BienaimeDirector
4
Filed May 27, 2026Period of report May 26, 20260001610717-26-000161
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 26, 2026
Ordinary SharesF1200$236.235$47.25K200Direct
PurchaseMay 26, 2026
Ordinary SharesF2200$239.3675$47.87K400Direct
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $235.93 to $236.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. F2The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $239.245 to $239.490 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Flemming Steen JensenSee Remarks
4
Filed May 12, 2026Period of report May 11, 20260001610717-26-000159
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 11, 2026
Ordinary Shares19,460$238.4903$4.64M0Direct
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.